Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
The U.S. stock market’s woes continued for the fourth consecutive week, with major indices closing in red amid trade and ...
The agency is advising people to avoid misusing or inhaling the products that are marketed as whipped cream chargers but have ...
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Investor's Business Daily on MSN7d
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedDexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback